BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38507268)

  • 21. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
    Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
    Front Public Health; 2022; 10():969030. PubMed ID: 36203704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.
    Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
    Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics analysis and prognostic nomogram for predicting survival in patients with second primary prostate cancer: a population study based on SEER database.
    Deng R; Zhou J; Qiu J; Cai L; Gong K
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11791-11806. PubMed ID: 37405473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomograms-based prediction of overall and cancer-specific survivals for patients diagnosed with major salivary gland carcinoma.
    Guo Z; Wang Z; Liu Y; Han J; Liu J; Zhang C
    Ann Transl Med; 2021 Aug; 9(15):1230. PubMed ID: 34532367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment.
    Wang T; Fu X; Zhang L; Liu S; Tao Z; Wang F
    Int J Clin Pract; 2023; 2023():9219067. PubMed ID: 37637510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
    Huang W; Bao Y; Luo X; Yao L; Yuan L
    Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
    Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
    Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomograms for predicting overall survival and cancer-specific survival of endometrioid ovarian carcinoma: A retrospective cohort study from the SEER database.
    Wang D; Ran X; He Y; Zhu L; Deng Y
    Int J Gynaecol Obstet; 2024 Apr; 165(1):194-202. PubMed ID: 38009672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
    Shen J; Zhou Y; Yu B; Zhao K; Ding Y
    Eur J Surg Oncol; 2023 Oct; 49(10):106966. PubMed ID: 37365056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].
    Zhang HD; Niu XD; Zhou XW; Yang Y; Li JM; Gan YJ; Wang X; Liu YH; Mao Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):588-596. PubMed ID: 35871728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.
    Zhou Q; Li AB; Lin ZQ; Zhang HZ
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E713-E720. PubMed ID: 32039945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
    Chen Q; Wang S; Lang JH
    J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
    Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
    Front Oncol; 2022; 12():940601. PubMed ID: 36439411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: A population-based analysis.
    Tong Y; Pi Y; Cui Y; Jiang L; Gong Y; Zhao D
    Front Oncol; 2022; 12():959804. PubMed ID: 36568161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
    Zhou W; Huang C; Yuan N
    Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
    Xiao R; Liu C; He W; Ma L
    Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
    Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
    Front Public Health; 2022; 10():946299. PubMed ID: 36159305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a Prognostic Nomogram for Cancer-Specific Survival in Patients With Base-of-Tongue Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database.
    Lin ZJ; Huang L; Lin YM; Luo R; Wang SC; Lyu J; Shao J
    Cancer Control; 2023; 30():10732748231210733. PubMed ID: 37969067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
    Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
    Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.